Goldberg discussed the FDA approval of Vabysmo (faricimab, Genentech) for the treatment of retinal vein occlusion (RVO) and the possible label expansion of high-dose aflibercept for the treatment ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback